Search research articles
Contact Us
Filters
Showing results (11-20 of 96) with videos related to
Page
of 10
Sort By:
Intervirology
|
July 19, 2014
Host factor-targeted hepatitis B virus therapies
Adam Gehring, Antonio Bertoletti, John E Tavis
Antimicrobial Agents and Chemotherapy
|
December 14, 2016
Synergistic Interactions between Hepatitis B Virus RNase H Antagonists and Other Inhibitors
Elena Lomonosova, Adam Zlotnick, John E Tavis
Virology
|
July 2, 2003
The duck hepatitis B virus polymerase and core proteins accumulate in different patterns from their common mRNA
Ermei Yao, Heinz Schaller, John E Tavis
Missouri Medicine
|
May 13, 2026
<i>In Silico</i> Studies of the Hepatitis B Virus Polymerase: Efforts to Identify Novel Drug Binding Sites to Inhibit HBV Replication
Razia Tajwar, Qilan Li, John E Tavis
Biological Procedures Online
|
October 13, 2006
Combining genetic and biochemical approaches to identify functional molecular contact points
Matthew P Badtke, Feng Cao, John E Tavis
The Journal of General Virology
|
July 19, 2000
Evidence that the first strand-transfer reaction of duck hepatitis B virus reverse transcription requires the polymerase and that strand transfer is not needed for the switch of the polymerase to the elongation mode of DNA synthesis
Yunhao Gong, Ermei Yao, Melissa Stevens, et al.
Antiviral Research
|
May 8, 2020
HBV replication inhibitors
Claire Pierra Rouviere, Cyril B Dousson, John E Tavis
Virology
|
June 4, 2014
Human pegivirus (GB virus C) NS3 protease activity inhibits induction of the type I interferon response and is not inhibited by HCV NS3 protease inhibitors
Adnan Y Chowdhury, John E Tavis, Sarah L George
The Journal of Biological Chemistry
|
March 5, 2022
Alpha-hydroxytropolones are noncompetitive inhibitors of human RNase H1 that bind to the active site and modulate substrate binding
Nathan L Ponzar, Razia Tajwar, Nicola Pozzi, et al.
Plos One
|
February 1, 2012
The GB virus C (GBV-C) NS3 serine protease inhibits HIV-1 replication in a CD4+ T lymphocyte cell line without decreasing HIV receptor expression
Sarah L George, Dino Varmaz, John E Tavis, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 96) with videos related to
Sort By:
Page
of 10
Intervirology
|
July 19, 2014
Host factor-targeted hepatitis B virus therapies
Adam Gehring, Antonio Bertoletti, John E Tavis
Antimicrobial Agents and Chemotherapy
|
December 14, 2016
Synergistic Interactions between Hepatitis B Virus RNase H Antagonists and Other Inhibitors
Elena Lomonosova, Adam Zlotnick, John E Tavis
Virology
|
July 2, 2003
The duck hepatitis B virus polymerase and core proteins accumulate in different patterns from their common mRNA
Ermei Yao, Heinz Schaller, John E Tavis
Missouri Medicine
|
May 13, 2026
<i>In Silico</i> Studies of the Hepatitis B Virus Polymerase: Efforts to Identify Novel Drug Binding Sites to Inhibit HBV Replication
Razia Tajwar, Qilan Li, John E Tavis
Biological Procedures Online
|
October 13, 2006
Combining genetic and biochemical approaches to identify functional molecular contact points
Matthew P Badtke, Feng Cao, John E Tavis
The Journal of General Virology
|
July 19, 2000
Evidence that the first strand-transfer reaction of duck hepatitis B virus reverse transcription requires the polymerase and that strand transfer is not needed for the switch of the polymerase to the elongation mode of DNA synthesis
Yunhao Gong, Ermei Yao, Melissa Stevens, et al.
Antiviral Research
|
May 8, 2020
HBV replication inhibitors
Claire Pierra Rouviere, Cyril B Dousson, John E Tavis
Virology
|
June 4, 2014
Human pegivirus (GB virus C) NS3 protease activity inhibits induction of the type I interferon response and is not inhibited by HCV NS3 protease inhibitors
Adnan Y Chowdhury, John E Tavis, Sarah L George
The Journal of Biological Chemistry
|
March 5, 2022
Alpha-hydroxytropolones are noncompetitive inhibitors of human RNase H1 that bind to the active site and modulate substrate binding
Nathan L Ponzar, Razia Tajwar, Nicola Pozzi, et al.
Plos One
|
February 1, 2012
The GB virus C (GBV-C) NS3 serine protease inhibits HIV-1 replication in a CD4+ T lymphocyte cell line without decreasing HIV receptor expression
Sarah L George, Dino Varmaz, John E Tavis, et al.
Page
of 10